Philipp Schommers

Durable suppression of viremia by lipid nanoparticle-formulated RNA encoding for a highly potent HIV-1 neutralizing antibody

This study demonstrates that lipid nanoparticle-formulated RNA encoding a potent HIV-1 neutralizing antibody can durably suppress viremia in humanized mice.

Geno2pheno: Interpretable and accurate HIV antibody resistance prediction

The paper develops a web service called geno2pheno[bNAbs] that predicts HIV-1 resistance to broadly neutralizing antibodies using statistical models and compares its performance to other methods.

Identification of a broad and potent V3 glycan site bNAb targeting anN332gp120 glycan-independent epitope

This paper identifies a potent, broad neutralizing antibody targeting a glycan-independent V3 epitope on HIV-1 Env, showing enhanced neutralization potency and resistance to escape mutations.

Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy

The paper identifies a new broadly neutralizing antibody, 04_A06, with high potency and breadth against HIV-1 strains, showing potential for prevention and therapy.

Swarm Learning as a privacy-preserving machine learning approach for disease classification

This paper introduces Swarm Learning, a decentralized machine learning approach for disease classification using transcriptomic data, demonstrating its effectiveness in developing classifiers for COVID-19, tuberculosis, and leukemias while preserving privacy.